期刊文献+

维持性血液透析患者自体动静脉内瘘失功的影响因素分析 被引量:39

Analysis of the Factors Relating to the Dysfunction in Autogenous Arteriovenous Fistula in Maintenance Hemodialysis Patients
下载PDF
导出
摘要 目的:回顾性分析维持性血液透析患者自体动静脉内瘘(AVF)失功的影响因素。方法:以我院血透中心73例首次发生自体AVF失功的患者为内瘘失功组,选取同期自体AVF功能良好的136例维持性血液透析患者为内瘘通畅组,比较两组患者各项临床及生化指标,分别进行单因素分析及logistic回归分析。结果:内瘘失功组和通畅组在年龄、糖尿病、血红蛋白、血清白蛋白、血小板、三酰甘油、血清铁、C反应蛋白(CRP)、血钾、血磷、甲状旁腺激素(PTH)等方面差异存在统计学意义(P<0.05);logistic回归分析显示患有糖尿病(OR=1.551),血清白蛋白(OR=1.061)、三酰甘油(OR=1.275)、血磷(OR=1.580)水平是内瘘失功的危险因素;内瘘失功组的生存分析显示糖尿病患者内瘘的中位生存时间为7个月,非糖尿病患者为27个月,差异有统计学意义(P=0.002);分别进行内瘘失功组和通畅组的组内比较,糖尿病患者与非糖尿病患者在血清白蛋白、三酰甘油、血磷方面差异存在统计学意义(P<0.05)。结论:糖尿病、血清白蛋白、三酰甘油、血磷水平是内瘘失功的危险因素,糖尿病患者内瘘使用时间明显短于非糖尿病患者,其影响因素与血清白蛋白、三酰甘油、血磷水平密切相关。 Objective:To analysis the risk factors for dysfunction in autogenous arteriovenous fistula ( AVF) in maintenance 1 hemodialysis ( MHD) patients. Methods:The fistula dysfunction group studied in this study included 73 MHD patients in hemodial-ysis center of our hospital who had AVF for blood access during hemodialysis and were found to have dysfunction in the AVF for the first time. The fistula patency group included 136 MHD patients whose AVF were well-functioning in the same period as the fistula dysfunction group. Their clinical and biochemical data were collected for analysis of variance and binary logistic regression analysis. Results:There were statistically differences (P〈0. 05) between the two groups in age, diabetes, hemoglobin, serum albumin, plate-lets, triglycerides, serum iron, CRP ( C-reactive protein) , serum potassium, phosphorus and PTH ( parathyroid hormone) . Logistic regression analysis demonstrated that diabetes (OR=1. 551), serum albumin (OR=1. 061), triglycerides (OR=1. 275) and serum phosphate (OR=1. 580) were the risk factors for fistula dysfunction. Survival analysis of fistula dysfunction group showed that the median survival of AVF was 7 months in patients with diabetic nephropathy, and was 27 months in patients with non-diabetic ne-phropathy, the difference was significant (P=0. 002). Comparison carried out within the fistula dysfunction group and unobstructed group, there was significant difference (P〈0. 05) in serum albumin, triglycerides and phosphorus with diabetic and non-diabetic patients. Conclusion:Diabetes, serum albumin, triglycerides and serum phosphate levels are a risk factors for fistula dysfunction. Di-abetic patients using the fistula was significantly shorter than non-diabetic patients, is closely related to its impact with serum albu-min, triglycerides, and blood phosphorus levels.
机构地区 解放军第
出处 《中国中西医结合肾病杂志》 2014年第11期961-964,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 南京军区医学科技创新项目(No.12MA017)
关键词 终末期肾脏病 血液透析 动静脉内瘘 糖尿病肾病 危险因素 End-stage renal disease Hemodialysis Arteriovenous fistula Diabetic kidney disease Risk factor
  • 相关文献

参考文献17

  • 1Kazemzadeh GH, Modaghegh MHS, Ravari HI, et al. Primary pa-tency rate of nativev AV fistula:long term follow up. Int I Clin Exp Med,2012,5(2) :173 - 178.
  • 2Huijbregts H J, Bots ML, Wittens CH, et al. Hemodialysis arterio- venous fistula pateney revisited: results of a prospective, multi- center initiative. Clini J Am Soei Nephrol, 2008,3 ( 3 ) : 714 - 719.
  • 3Fahrtash F, Kairaitis L, Gruenewald S, et al. Defining a Signifi- cant stenosis in an autologous radio - cephalic arteriovenous fis- tula for hemodialysis. Seminars in Dialysis, 2011,24 ( 2 ) : 231 - 238.
  • 4Kaufman JS, O "Connor TZ, Zhang JH, et al. Randomized con- trolled trial of elopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol,2003,14(9) :2313 - 2321.
  • 5Diehm N, Van den Berg JC, Sehnyder V, et al. Determinants of haemodialysis access survival. Vasa, 2010,39 (2) : 133 - 139.
  • 6Chang TI, Paik J, Greene T, et ol. Intradialytie hypotension and vascular access thrombosis. J Am Soc Nephrol, 2011,22 ( 8 ) : 1526 - 1533.
  • 7阿勇,崔天蕾,金骊珠,付平.自体动静脉内瘘早期功能障碍临床分析[J].中国中西医结合肾病杂志,2011,12(2):165-166. 被引量:19
  • 8马祖等,陈的铃,杨正林,张益民.维持性血液透析患者动静脉内瘘血栓形成影响因素分析[J].中国血液净化,2009,8(10):544-546. 被引量:36
  • 9Maahs DM, Ogden LG, Dabelea D, et al. Association of glycae- mia with lipids in adults with type idiabetes: modification by dyslipidaemia medication. Diabetologia, 2010,53 ( 12 ) : 2518 - 2525.
  • 10Danis R, Ozmen S, Akin D, et al. Thmmbophilias and arter- lovenous fistula dysfunction in maintenance hemodialysis. Jour- nal of Thrombosis and ThromlMysis ,2009,27 (3) :307 - 315.

二级参考文献22

  • 1Ghislaine Medkouri, Rachid Aghai, Aabdelkbir Anabi, et al. Analysis of vascular access in hemodialysis patients: a report from a dialysis unit in casablanca[J]. Saudi J Kindney Dis Transplant, 2006,17:516-520.
  • 2Greg A. Knoll, Philip S. Wells, Darlene Young, et al. Thrombophilia and the risk for hemodialysis vascular access thrombosis[J]. J Am Soc Nephrol, 2005,16:1108-1114.
  • 3Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions[J]. Kindney Int, 2002,62:1109- 1124.
  • 4Edwin Wijnen, Niis Planken, Xavier Keuter, et al. Impact of a quality improvement programme based on vascular access flow monitoring on costs, access occlusion and access failure[J]. Nephrol Dia Transplant, 2006,21:3514-3519.
  • 5Pietro Ravani, Lawrence M. Spergel, Arif Asif, et al. Clinical epidemiology of arteriovenous fistula in 2007 [J]. J Nephrol, 2007,20:141- 149.
  • 6Pasceri V, Chang J, Willerson JT, Yeh ET. Modulation of Creactive protein mediated monoeyte chemoattractant protein-1 induction in human endothelial cells by anti-ath eroselerosis drugs[J]. Circulation, 2001, 103:2531- 2534.
  • 7Costa E, Rocha S, Rocha Pereira P, et al. Cross-talk between inflammation, coagulation fibrinolysis and vascular access in hemodialysis patients[J]. J Vasc Access, 2008,9:248 -253.
  • 8NKF-K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendation 2006:Updates:Vasoular Acuss,AJKD,2006,48:s1-s322.
  • 9Roy-Chaudhury P,Sukhatme VP,Cheng AK.Hemodialysis vascular access dysfunction:a cellular and molecular viewpoint.J Am Soc Nephrol,2006,17(4):1112-1127.
  • 10Beathard GA,Arnold P,Jackson J,et al.Aggressive treatment of early fistula failure.Kidney Int,2004,66(3):1289.

共引文献61

同被引文献298

引证文献39

二级引证文献342

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部